Novo Nordisk Frontier 4

News

Novo Nordisk ousts CEO

Novo Nordisk ousts CEO after falling behind in weight loss market

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Fox Business on MSN · 18h

Novo Nordisk CEO steps down as Wegovy maker faces increased competition

As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the competitive weight-loss drug market.

New York Post on MSN · 19h

Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has

16hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

21hon MSN

Talks to replace Novo Nordisk CEO lasted several weeks, board chair says

Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...

Zacks Investment Research on MSN1d

ETFs to Capitalize on the Novo Nordisk-Septerna Deal

Novo Nordisk NVO announced a significant partnership with Septerna SEPN, a U.S.-based biotech company, valued at up to $2.2 billion, to tap the growing obesity treatment market. Following the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk ousts CEO

Trending now